Purchases and Sales Made in Q3 2023 in Iovance Biotherapeutics, Inc. (IOVA)
This table provides information about the institutional ownership of Iovance Biotherapeutics, Inc. (IOVA) during Q3 2023. The information is specifically focused on institutions that hold shares of IOVANCE BIOTHERAPEUTICS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2023
Q3 2023
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-1.3M- 85.17% |
$5.79M - $11.5M
|
227K
$531K
|
|
|
Nov 13, 2023
Q3 2023
|
Norges Bank
Oslo, Q8 |
SELL
|
- |
-1.4MClosed |
$6.2M - $12.3M
|
0
$0
|
|
|
Nov 14, 2023
Q3 2023
|
Perceptive Advisors LLC
New York, NY |
SELL
|
- |
-2.07M- 14.77% |
$9.21M - $18.2M
|
12M
$28M
|
|
|
Nov 09, 2023
Q3 2023
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-2.81M- 84.8% |
$12.5M - $24.7M
|
503K
$1.18M
|
|
|
Nov 14, 2023
Q3 2023
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-6.37M- 81.86% |
$28.3M - $56M
|
1.41M
$3.31M
|